All good and protects program! You would need to prove your patient works to receive it so shows program coming along nicely and just awaiting approval for phase 1. Won't add anything to SP today as we already have US approval but another piece in the jigsaw to me. GLA
is definitely not my interpretation of what is imo, a totally unacceptable and disrespectful lack of news flow by 'Timbo' to SAR's loyal and (some) still trusting shareholders! High time that the CEO of this Cos pulled his finger out and started to communicate honestly and concisely as to just what the state of development is in respect of SAR's full range of compounds under development and in so doing, articulate said information to his Private Investors via an appropriately worded rns.
interesting that he deviated from the last two years when they gave a trading update (July in 2012 and August in 2013).
Not complaining at all - happy(ish) to keep waiting and adopting the no news is good news mantra (aren't we all!) but interested that he has deviated from the timetable whilst claiming not to have done (although the last two years could of course be the deviations!!)
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.